Whitehawk Therapeutics Inc (WHWK)

NASDAQ:WHWK

Whitehawk Therapeutics Inc

—

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

2017

Founded

Country

—

CEO

—

Fulltime Employees

-16.00

PE Ratio

-0.69

Relative PE Ratio

0.00%

Dividend Yield

USD 4.76

Stock Price

+1.28%

1D Change

USD 4.88

52W High

USD 1.57

52W Low

52W Range

$329,567.86K

Market Cap

$7,145.00K

Revenue

$-20,596.00K

Net Income

-288.26 %

Net Margin

$123,043.00K

Cash

Debt

$206,524.86K

Enterprise Value

$-114,400.00K

Operating Profit

$-97,433.00K

Operating Cash Flow

$552.00K

CapEx

$-97,985.00K

Free Cash Flow

-9.97 %

Net Income / EV

-47.18 %

OCF / EV

-47.44 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Capital Allocation Latest News

—

Daily adjusted close

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

2017

Founded

Country

—

CEO

—

Fulltime Employees

7.15M USD

Revenue

-20.6M USD

Net Income

-288.26 %

Net Margin

0.00%

Dividend Yield

-16.00

PE Ratio

-0.69

Relative PE Ratio

$4.88

52W High

$1.57

52W Low

52w Range

329.57M USD

Market Cap

123.04M USD

Cash

0 USD

Debt

206.52M USD

Enterprise Value

-114.4M USD

Operating Profit

-97.43M USD

Operating Cash Flow

552K USD

CapEx

-97.99M USD

Free Cash Flow

-9.97 %

Net Income / EV

-47.18 %

OCF / EV

-47.44 %

FCF / EV

Actions

Website Investor Relations

AI Actions

Explain Business Moat Analysis Key business risks Management Analysis Balance Sheet Analysis Normalize Earnings Growth Drivers Dividend Track Record Capital Allocation Latest News

$WHWK

Whitehawk Therapeutics Inc

-9.97 %

Net Income / EV

-47.18 %

Operating Cash Flow / EV

-47.44 %

Free Cash Flow / EV

Key stats based on share price of USD 4.76, as of 7, August 2026.

View more and calculate expected returns for free on www.aiir.finance

AIIR Finance

Key Stats

Market Cap$329,567.86K

- Cash$123,043.00K

+ Debt$0

Enterprise Value$206,524.86K

Revenue$7,145.00K

Gross Profit89.36 % | $6,385.00K

Operating Profit-1601.12 % | $-114,400.00K

Net Income-288.26 % | $-20,596.00K

Operating Cash Flow$-97,433.00K

CapEx$552.00K

Free Cash Flow$-97,985.00K

Net Income / EV-9.97 %

OCF / EV-47.18 %

FCF / EV-47.44 %